UK MHRA · May 11, 2026

MHRA opens UK-wide consultation on redefining gene therapies

MHRA consults on proposed changes to how gene therapies are defined in UK legislation to align with scientific and technological developments.

Medium impact Pharmaceuticals Clinical Trials & Research UK pharmaceuticals

To future-proof the sector and ensure regulation keeps up with scientific and technological developments, the MHRA is consulting on proposed changes to how gene therapies are defined in UK legislation.

Read the official source ↗

Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.